# South Korea Articaine Hydrochloride Market

> South Korea Articaine Hydrochloride Market Research Report By Application (infiltration, nerve block, others) and By End User (dental, clinics, hospitals, academics &amp; research institutes) -Forecast to 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.48%
- **2024:** $ 43.9 Million
- **2025:** $ 47.62 Million
- **2035:** $ 107.45 Million
- **Key Players:** Septodont (FR), Dentsply Sirona (US), Patterson Companies (US), Heraeus Kulzer (DE), 3M (US), B. Braun Melsungen AG (DE), MediSafe (IN), Nobel Biocare (CH)

**Report ID:** MRFR/HC/54642-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-articaine-hydrochloride-market-56408

---

## Market Summary

## **South Korea Articaine Hydrochloride Market Overview**

As per MRFR analysis, the South Korea Articaine Hydrochloride Market Size was estimated at 40.5 (USD Million) in 2023. The South Korea Articaine Hydrochloride Market Industry is expected to grow from 43.75(USD Million) in 2024 to 109.69 (USD Million) by 2035. The South Korea Articaine Hydrochloride Market CAGR (growth rate) is expected to be around 8.715% during the forecast period (2025 - 2035).

**Key South Korea Articaine Hydrochloride Market Trends Highlighted**

The South Korea Articaine Hydrochloride Market is witnessing several significant trends that are shaping its future trajectory. One of the key market drivers is the increasing prevalence of dental procedures, as South Korea places a strong emphasis on oral health and aesthetic improvements. The population's keen interest in cosmetic dentistry is further propelling the demand for effective and safe anesthetic options like Articaine Hydrochloride.

Moreover, advancements in dental practices and a rise in dental tourism in South Korea have created opportunities for dental clinics to adopt more effective anesthetics, catering to both local and international patients seeking high-quality dental care.Opportunities exist in the South Korea Articaine Hydrochloride market for the development of new dosage forms and innovative combinations of Articaine Hydrochloride.

The increasing enrollment of dental schools and training programs supported by the Korean Dental Association is improving the training of dental professionals, which enhances the use of anesthetics.

Moreover, the strong supply and control system of the country assures that there is a constant and ready supply of Articaine Hydrochloride to meet the increasing demands. Recent changes show there is a considerable focus on the safety and comfort of the patients, which makes dentists prefer the use of Articaine as it is less toxic systemically than other anesthetics.

This trend aligns with South Korea’s healthcare mission to improve patient outcomes through advanced medical practices and technologies. Overall, the South Korea Articaine Hydrochloride Market is evolving rapidly, driven by changing patient expectations and the adaptation of dental practices that focus on minimizing discomfort while maximizing efficacy.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**South Korea Articaine Hydrochloride Market Drivers**

**Growing Demand for Dental Anesthesia**

The South Korea Articaine Hydrochloride Market Industry is experiencing a significant increase in demand for dental anesthesia, driven by the rising prevalence of dental diseases and the growing population seeking dental care. According to the South Korean Ministry of Health and Welfare, dental problems affect approximately 60% of adults over the age of 30, indicating a substantial need for effective pain management solutions in dental procedures.

Furthermore, the increasing number of dental clinics in South Korea, which reached over 38,000 by 2022, is contributing to higher consumption of Articaine Hydrochloride in dental practices. Prominent dental associations in South Korea, such as the Korean Dental Association, have been advocating for the use of advanced anesthetic agents like Articaine to enhance patient comfort, thus further fueling market growth within this sector.

**Advancements in Medical Technologies**

Innovative advancements in medical technologies are proving to be a key driver of the South Korea Articaine Hydrochloride Market Industry. The integration of digital platforms and advanced surgical techniques has revolutionized how dental and medical procedures are performed.

According to the South Korean Ministry of Science and Technology, investment in Health Information Technology (HIT) has increased by 15% over the last five years, leading to improved patient outcomes.

Tools that allow for better diagnostics and enhanced patient care have created opportunities for tools like Articaine Hydrochloride to be more widely used in conjunction with these advanced medical modalities. As these technologies evolve, practitioners increasingly prefer products that offer superior efficacy and safety profiles, like Articaine.

**Increasing Awareness of Pain Management**

There is a noticeable rise in consumer awareness regarding proper pain management practices in South Korea, which is important in influencing the South Korea Articaine Hydrochloride Market Industry. Initiatives and campaigns by the South Korean government aimed at educating the public on the importance of pain management in medical procedures are pivotal.

Reports from the South Korean Public Health Agency indicate that between 2018 and 2022, there was a 25% increase in public inquiries about pain management options.

This increased awareness has led to heightened demand for effective anesthetics, including Articaine Hydrochloride, as healthcare professionals prioritize patient comfort. As a result, major pharmaceutical companies are focusing their Research and Development efforts on improving formulations and delivery methods for anesthetic agents.

**South Korea Articaine Hydrochloride Market Segment Insights**

**Articaine Hydrochloride Market Application Insights**

The South Korea Articaine Hydrochloride Market is characterized by diverse applications, each playing a crucial role in the overall industry landscape. As the market continues to grow, the application segment is primarily driven by the increasing demand for efficient dental procedures and the need for effective pain management solutions.

Among the various applications, infiltration is notable for its widespread use in local anesthesia during dental surgeries, catering to both dental professionals and patients looking for less invasive treatment options.Similarly, nerve block techniques are gaining significance, offering targeted pain relief that enhances surgical outcomes and patient comfort.

This method is particularly important for more complex procedures where precise anesthesia is critical. The variety within applications allows for tailor-made solutions that address specific patient needs, which is essential in a rapidly evolving medical landscape. Other methods are also gaining traction, contributing to market growth by providing alternatives and complementing existing therapies.

With healthcare professionals in South Korea focusing on improving patient experiences and surgical efficacy, the application segment of the South Korea Articaine Hydrochloride Market is expected to witness significant advancements and innovations.The increasing adoption of Articaine Hydrochloride in various forms is indicative of its pivotal role in modern dentistry, reinforcing the importance of this segment in improving health outcomes while responding to the evolving dynamics of patient care and treatment.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Articaine Hydrochloride Market End User Insights**

The South Korea Articaine Hydrochloride Market is significantly characterized by its diverse End User segment, which includes dental practices, clinics, hospitals, and academic and research institutes. The dental segment plays a crucial role in the demand for Articaine Hydrochloride, as it is widely used for various dental procedures due to its effective local anesthetic properties. Clinics also contribute notably to the market, given their accessibility and increased patient flow, while hospitals represent a considerable share owing to the need for anesthesia in surgical operations.

Additionally, academic and research institutes are pivotal for advancing the understanding and applications of Articaine Hydrochloride through ongoing studies and clinical trials. Notably, the growing emphasis on oral health and surgical procedures in South Korea drives the demand within these segments.

The market is witnessing trends such as the rising focus on pain management during procedures and increased investments in healthcare infrastructure, which further enhances the significance of these end users. Consequently, this segment demonstrates robust opportunities for growth stemming from evolving healthcare policies and increasing awareness regarding patient care in South Korea.

**South Korea Articaine Hydrochloride Market Key Players and Competitive Insights**

The South Korea Articaine Hydrochloride Market is characterized by a dynamic competitive landscape marked by various manufacturers and suppliers aiming to capture market share in the growing demand for effective local anesthetic solutions.

Articaine Hydrochloride is widely favored in the dental industry for its efficacy and relatively low toxicity profile, positioning it as a preferred choice among practitioners. Market dynamics are influenced by factors such as regulatory changes, innovations in medication formulations, pricing strategies, and the prevalence of dental care services in the region.

Understanding the competitive landscape is vital for stakeholders seeking to enhance their market positioning and develop strategies that cater to the evolving needs of both healthcare providers and patients.In the South Korea Articaine Hydrochloride Market, Hanmi Pharmaceutical has established itself as a significant player, showcasing strengths primarily in innovation and high-quality manufacturing.

With a robust R&D capability, the company continuously seeks to improve its product offerings and respond to market needs effectively. Hanmi Pharmaceutical's commitment to quality pharmaceutical practices has enabled it to gain trust among dental practitioners who rely on reliable anesthetic solutions.

The company's extensive distribution network further enhances its market presence, making its products widely accessible across healthcare facilities. Additionally, its focus on strategic partnerships and collaborations within the healthcare sector strengthens its competitive edge in the local market.

Seegene is another key player in the South Korea Articaine Hydrochloride Market, recognized for its advancements in molecular diagnostic techniques that complement its pharmaceutical offerings. While primarily known for its diagnostic solutions, Seegene emphasizes the development of products that support local anesthesia, thereby aligning itself with the growth of articaine usage in dental applications.

The company's unique position in the market is augmented by its strong investment in research and development, allowing it to introduce innovative products that meet stringent healthcare requirements.

Seegene has also engaged in strategic mergers and acquisitions that enhance its capabilities and allow for more efficient production processes. This positions the company favorably in the competitive landscape while enabling it to better serve the needs of healthcare practitioners in South Korea, particularly in relation to intraoperative analgesia and patient management solutions.

**Key Companies in the South Korea Articaine Hydrochloride Market Include**

- Hanmi Pharmaceutical
- Seegene
- Korea United Pharm
- Janssen Pharmaceuticals
- Medytox
- Hugel
- Samyang Biopharmaceuticals
- Pharmavit
- Daewoong Pharmaceutical
- Celltrion Healthcare
- Samsung Biologics
- PharmAbcine
- Ubiquitous
- Green Cross
- DongA ST

**South Korea Articaine Hydrochloride Market Industry Developments**

The South Korea Articaine Hydrochloride Market has recently experienced notable developments, particularly with major companies like Hanmi Pharmaceutical and Celltrion Healthcare focusing on expanding their portfolios and strengthening their market presence. In July 2023, Hanmi Pharmaceutical announced the enhancement of its production capabilities for Articaine Hydrochloride to meet the rising demand in dental applications.

Korea United Pharm and Samsung Biologics also noted substantial growth in their market valuation, impacting overall competitiveness in the sector. Mergers and acquisitions in the market have seen activity, with Seegene acquiring a smaller biotech firm in August 2023 to diversify its offerings and research capabilities relevant to Articaine Hydrochloride.

Moreover, Medytox has been investing significantly in Research and Development initiatives to improve formulation efficiency. Over the last few years, major occurrences, such as the certification of new production facilities in March 2022 by Hugel, have contributed to a more robust supply chain for Articaine Hydrochloride.

The market outlook remains optimistic as companies explore new opportunities to innovate and increase their market share in this essential pharmaceutical segment, aligning with South Korea’s proactive healthcare policies and initiatives.

**South Korea Articaine Hydrochloride Market Segmentation Insights**

**Articaine Hydrochloride Market Application****Outlook**

- infiltration
- nerve block
- others

**Articaine Hydrochloride Market End User****Outlook**

- dental
- clinics
- hospitals
- academics & research institutes

## Market Drivers

### Growing Dental Health Awareness

The increasing awareness regarding dental health in South Korea is a significant driver for the articaine hydrochloride market. As the population becomes more informed about the importance of oral hygiene and regular dental check-ups, the demand for dental procedures is likely to rise. This trend is supported by various health campaigns and educational programs that emphasize preventive care. Consequently, The articaine hydrochloride market will experience growth as dental practitioners seek effective anesthetic options to enhance patient comfort during procedures. The market's expansion could be further evidenced by a projected increase in dental visits, with estimates suggesting a rise of approximately 15% in the next few years. This heightened focus on dental health is expected to bolster the demand for articaine hydrochloride, positioning it as a preferred choice among dental professionals.

### Rising Number of Dental Clinics

The proliferation of dental clinics across South Korea is a significant factor influencing the articaine hydrochloride market. With an increasing number of dental practices opening, there is a corresponding rise in the demand for anesthetic agents to facilitate various dental procedures. This trend is indicative of a broader shift towards accessible dental care, which is likely to enhance the utilization of articaine hydrochloride. Market data suggests that the number of dental clinics has increased by approximately 20% over the past five years, reflecting a growing emphasis on oral health services. As more clinics emerge, the competition among dental practitioners may drive the adoption of effective anesthetics, further propelling the articaine hydrochloride market. This expansion could lead to a more diverse range of applications for articaine hydrochloride in various dental procedures.

### Increasing Cosmetic Dentistry Trends

The rising popularity of cosmetic dentistry in South Korea is a driving force for the articaine hydrochloride market. As more individuals seek aesthetic dental procedures, the demand for effective anesthetics to ensure patient comfort during these treatments is likely to grow. Cosmetic procedures, such as teeth whitening, veneers, and orthodontics, often require anesthesia to manage discomfort, thereby increasing the utilization of articaine hydrochloride. Market analysis indicates that the cosmetic dentistry sector has expanded significantly, with a projected growth rate of around 12% annually. This trend suggests that dental practitioners will increasingly rely on articaine hydrochloride to provide a pain-free experience for patients undergoing cosmetic enhancements. Consequently, the articaine hydrochloride market may experience a notable uptick in demand as cosmetic dentistry continues to gain traction.

### Regulatory Support for Dental Anesthetics

Regulatory frameworks in South Korea are increasingly supportive of the use of anesthetics in dental practices, which may positively impact the articaine hydrochloride market. The government has implemented guidelines that facilitate the safe and effective use of dental anesthetics, ensuring that practitioners have access to high-quality products. This regulatory environment is likely to encourage dental professionals to adopt articaine hydrochloride as a preferred anesthetic option, given its favorable safety profile and efficacy. Additionally, the market may benefit from ongoing research and development initiatives aimed at enhancing the formulation and delivery of anesthetics. As regulatory bodies continue to endorse the use of effective anesthetics, the articaine hydrochloride market could see a potential increase in demand, contributing to its overall growth trajectory in the coming years.

### Technological Innovations in Dental Practices

Technological advancements in dental practices are likely to play a crucial role in shaping the articaine hydrochloride market. Innovations such as digital imaging, laser dentistry, and computer-assisted anesthesia systems are enhancing the efficiency and effectiveness of dental procedures. These technologies not only improve patient outcomes but also increase the demand for reliable anesthetics like articaine hydrochloride. As dental clinics in South Korea adopt these modern technologies, the need for high-quality anesthetics that provide rapid onset and effective pain control becomes paramount. The articaine hydrochloride market may benefit from this trend, as practitioners seek to integrate advanced techniques with effective anesthetic solutions. Furthermore, the market could see a potential growth rate of around 10% annually, driven by the increasing adoption of these technologies in dental practices.

## Future Outlook

The [Articaine Hydrochloride Market](https://www.marketresearchfuture.com/reports/articaine-hydrochloride-market-2542) is projected to grow at 8.48% CAGR from 2025 to 2035, driven by increasing dental procedures and demand for effective anesthetics.

**New opportunities:**

- Development of innovative delivery systems for enhanced patient comfort.
- Expansion into veterinary applications for dental procedures.
- Strategic partnerships with dental clinics for exclusive supply agreements.

By 2035, the market is expected to achieve robust growth, positioning itself as a leader in dental anesthetics.

## Segment Insights

### By Application: Infiltration (Largest) vs. Nerve Block (Fastest-Growing)

In the South Korea articaine hydrochloride market, the application segment is predominantly led by infiltration, which commands a significant portion of the market. Nerve block is also a vital player, though it currently holds a smaller market share. The presence of both applications highlights the versatility of articaine, with clinicians opting for different approaches based on specific procedures and patient needs. The category of 'others' serves niche requirements, but its impact on overall share remains minimal compared to the leading segments.

Growth trends within the application segment are influenced by advancements in dental procedures and an increasing preference for local anesthetics in outpatient dental care. Nerve block is witnessing the highest growth rate due to its effectiveness in specific surgical procedures, which enhances patient comfort and reduces recovery time. The growing awareness of different anesthetic techniques and their benefits among dental professionals further propels the adoption of these applications, positioning them favorably within the market.

Infiltration (Dominant) vs. Nerve Block (Emerging)

Infiltration stands out as the dominant application in the South Korea articaine hydrochloride market, primarily due to its applicability in a broad range of dental procedures, providing effective pain management during routine and complex treatments. Its established acceptance among clinicians ensures its continued relevance. Meanwhile, nerve block is emerging as a crucial application, recognized for its targeted pain relief, especially in surgical environments. This method, although currently smaller in market share, is gaining traction among dental practitioners, driven by its advantages in minimizing post-operative discomfort. Both applications together illustrate the dual nature of articaine's efficacy, catering to diverse dental needs.

### By End User: Dental Clinics (Largest) vs. Hospitals (Fastest-Growing)

In the South Korea articaine hydrochloride market, Dental Clinics hold the largest share, owing to the increasing number of dental procedures and the demand for local anesthetics in outpatient settings. Hospitals, while currently having a smaller share, are witnessing rapid growth as they expand their dental departments and incorporate articaine in more surgical procedures.

The growth in the segment is primarily driven by the rising prevalence of dental disorders and the significant focus on pain management in surgical settings. Furthermore, the evolving guidelines in dental practices favor the use of articaine due to its effectiveness and safety profile. This trend is fostering greater adoption in hospitals, making them the fastest-growing segment as they cater to an increasing patient base needing dental care.

Dental Clinics (Dominant) vs. Hospitals (Emerging)

Dental Clinics are the dominant player in the South Korea articaine hydrochloride market, characterized by their vast number and accessibility to patients. They utilize articaine extensively due to its rapid onset and favorable properties, making it the preferred choice for dental anesthesia. On the other hand, Hospitals represent an emerging segment as they increasingly adopt articaine for various surgical procedures, reflecting a transition in pain management strategy. The strategic focus on improving patient care and anesthesia outcomes is propelling Hospitals to incorporate more articaine in clinical practices, thereby expanding their market presence and fulfilling an essential role in comprehensive pain management.

## Competitive Benchmarking

The articaine hydrochloride market exhibits a dynamic competitive landscape, characterized by a blend of innovation and strategic partnerships among key players. Companies such as Septodont (FR), Dentsply Sirona (US), and B. Braun Melsungen AG (DE) are at the forefront, leveraging their extensive research and development capabilities to enhance product offerings. Septodont (FR) has focused on expanding its product portfolio through innovative formulations, while Dentsply Sirona (US) emphasizes digital transformation in dental practices, integrating advanced technologies into their service delivery. B. Braun Melsungen AG (DE) appears to be concentrating on regional expansion, particularly in Asia, to capture emerging market opportunities. Collectively, these strategies contribute to a competitive environment that is increasingly driven by technological advancements and customer-centric solutions.Key business tactics within the market include localizing manufacturing and optimizing supply chains to enhance efficiency and responsiveness. The competitive structure is moderately fragmented, with several players vying for market share. This fragmentation allows for diverse offerings, yet the influence of major companies remains substantial, as they set benchmarks for quality and innovation that smaller firms strive to meet.

In October  Dentsply Sirona (US) announced a strategic partnership with a leading technology firm to develop AI-driven solutions for dental practices. This collaboration is poised to revolutionize patient management and treatment planning, indicating a shift towards integrating artificial intelligence into everyday dental procedures. Such advancements not only enhance operational efficiency but also improve patient outcomes, positioning Dentsply Sirona as a leader in the digital transformation of dental care.

In September  B. Braun Melsungen AG (DE) launched a new line of articaine hydrochloride products tailored for the Asian market, reflecting its commitment to regional customization. This move is strategically significant as it allows the company to cater to local preferences and regulatory requirements, thereby strengthening its market presence in a rapidly growing region. The localized approach may also enhance customer loyalty and brand recognition.

In August  Septodont (FR) unveiled a novel formulation of articaine hydrochloride that promises reduced onset time and enhanced efficacy. This innovation is crucial in a competitive landscape where product differentiation is key. By prioritizing research and development, Septodont not only addresses the evolving needs of dental professionals but also reinforces its position as a pioneer in the market.

As of November  current trends in the articaine hydrochloride market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. The competitive differentiation is likely to evolve from traditional price-based strategies to a focus on technological advancements, product innovation, and supply chain reliability, suggesting a transformative shift in how companies compete in this sector.

## Recent News & Developments

The South Korea Articaine Hydrochloride Market has recently experienced notable developments, particularly with major companies like Hanmi Pharmaceutical and Celltrion Healthcare focusing on expanding their portfolios and strengthening their market presence. In July 2023, Hanmi Pharmaceutical announced the enhancement of its production capabilities for Articaine Hydrochloride to meet the rising demand in dental applications.

Korea United Pharm and Samsung Biologics also noted substantial growth in their market valuation, impacting overall competitiveness in the sector. Mergers and acquisitions in the market have seen activity, with Seegene acquiring a smaller biotech firm in August 2023 to diversify its offerings and research capabilities relevant to Articaine Hydrochloride.

Moreover, Medytox has been investing significantly in Research and Development initiatives to improve formulation efficiency. Over the last few years, major occurrences, such as the certification of new production facilities in March 2022 by Hugel, have contributed to a more robust supply chain for Articaine Hydrochloride.

The market outlook remains optimistic as companies explore new opportunities to innovate and increase their market share in this essential pharmaceutical segment, aligning with South Korea’s proactive healthcare policies and initiatives.

## Report Scope

| MARKET SIZE 2024 | 43.9(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 47.62(USD Million) |
| MARKET SIZE 2035 | 107.45(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.48% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Septodont (FR), Dentsply Sirona (US), Patterson Companies (US), Heraeus Kulzer (DE), 3M (US), B. Braun Melsungen AG (DE), MediSafe (IN), Nobel Biocare (CH) |
| Segments Covered | Application, End User |
| Key Market Opportunities | Growing demand for effective dental anesthetics drives innovation in the articaine hydrochloride market. |
| Key Market Dynamics | Rising demand for articaine hydrochloride in dental procedures drives competitive dynamics and regulatory scrutiny in South Korea. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What was the market valuation of articaine hydrochloride in South Korea in 2024?**
A: The market valuation was $43.9 Million in 2024.

**Q: What is the projected market valuation for articaine hydrochloride in South Korea by 2035?**
A: The projected market valuation for 2035 is $107.45 Million.

**Q: What is the expected CAGR for the South Korea articaine hydrochloride market during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 8.48%.

**Q: Which companies are considered key players in the South Korea articaine hydrochloride market?**
A: Key players include Septodont, Dentsply Sirona, Patterson Companies, Heraeus Kulzer, 3M, B. Braun Melsungen AG, MediSafe, and Nobel Biocare.

**Q: What were the segment valuations for the application of articaine hydrochloride in 2024?**
A: In 2024, the segment valuations were $15.0 Million for Infiltration, $20.0 Million for Nerve Block, and $8.9 Million for Others.

**Q: What are the projected segment valuations for dental clinics in the South Korea articaine hydrochloride market by 2035?**
A: By 2035, the projected valuation for dental clinics is expected to reach $36.0 Million.

**Q: How does the market for hospitals compare to that of dental clinics in 2024?**
A: In 2024, the market for hospitals was valued at $20.0 Million, while dental clinics were valued at $15.0 Million.

**Q: What is the expected growth trend for the South Korea articaine hydrochloride market from 2025 to 2035?**
A: The market is expected to grow steadily, with a projected CAGR of 8.48% from 2025 to 2035.

**Q: What were the segment valuations for end users in the South Korea articaine hydrochloride market in 2024?**
A: In 2024, the segment valuations for end users were $15.0 Million for Dental Clinics, $20.0 Million for Hospitals, and $8.9 Million for Academics &amp; Research Institutes.

**Q: What might influence the growth of the South Korea articaine hydrochloride market in the coming years?**
A: Factors such as increasing demand in dental practices and advancements in anesthetic techniques may influence market growth.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-articaine-hydrochloride-market-56408*
